Prenatal exposure to zidovudine affects mouse neurobehavioural development

I Branchi , A Venerosi , E Alleva , V Puopolo
EUROPEAN JOURNAL OF NEUROSCIENCE 10 292 -292

1998
Neonatal immunolesions of medial septal area and nucleus basalis magnocellularis differentially affect response to spatial novelty.

L Ricceri , A Usiello , G Calamandrei , J Berger-Sweeney
EUROPEAN JOURNAL OF NEUROSCIENCE 10 258 -258

1998
Amano, M., see Hasegawa, M., 93

J Bauer , SM Boye , PP Rompr , G Calamandrei
Brain Research 78 247 -248

1996
Endocrine disrupters: evaluation and prevention of possible risks to human health.

G. Calamandrei , A. Mantovani , C. la Rocca , A. V. Pesciolini
Rapporti ISTISAN - Istituto Superiore di Sanità

2009
Conference "autism and related disorders: state of services and research in Italy".

M. L. Scattoni , G. Calamandrei , F. Chiarotti
Notiziario dell'Istituto Superiore di Sanità 22 ( 9) 6 -9

2009
HENVINET - a European network on health and environment to reduce risk for childrens' health.

G. Calamandrei
Notiziario dell'Istituto Superiore di Sanità 23 ( 4) 3 -5

2010
Effects of prenatal zidovudine treatment on learning and memory capacities of preweanling and young adult mice.

E. Alleva , G. Calamandrei , I. Branchi , A. Venerosi
Neurotoxicology 20 ( 1) 17 -26

21
1999
NERVE GROWTH FACTOR DOES NOT AMELIORATE THE INFANTILE FORGETTING SYNDROME OF NEONATAL MICE

E. Alleva , F. Cirulli , G. Calamandrei , L. Aloe
Monitore Zoologico Italiano-Italian Journal of Zoology 22 ( 2) 235 -243

2
1988
Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 huntington's disease mice

M.R. Domenici , M.L. Scattoni , A. Martire , G. Lastoria
Neurobiology of Disease 28 ( 2) 197 -205

58
2007
Sex dimorphic behaviors as markers of neuroendocrine disruption by environmental chemicals: the case of chlorpyrifos.

A. Venerosi , L. Ricceri , S. Tait , G. Calamandrei
Neurotoxicology 33 ( 6) 1420 -1426

45
2012
Regenerative medicine in Huntington’s disease: Strengths and weaknesses of preclinical studies

A.M. Tartaglione , P. Popoli , G. Calamandrei
Neuroscience & Biobehavioral Reviews 77 32 -47

4
2017
Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behaviour and neuroendocrine systems

C. Frye , E. Bo , G. Calamandrei , L. Calzà
Journal of Neuroendocrinology 24 ( 1) 144 -159

475
2012
Effects of the food contaminant semicarbazide following oral administration in juvenile Sprague-Dawley rats.

F. Maranghi , R. Tassinari , V. Lagatta , G. Moracci
Food and Chemical Toxicology 47 ( 2) 472 -479

38
2009
P58 SHORT-TERM BEHAVIOURAL EFFECTS OF NEONATAL BASAL FOREBRAIN CHOLINERGIC LESIONS IN RATS

M.L. Scattoni , G. Calamandrei , L. Ricceri
Behavioural Pharmacology 15 ( 5) A25

2004
The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum

A. Pintor , M.T. Tebano , A. Martire , R. Grieco
Neuropharmacology 51 ( 5) 1004 -1012

62
2006
Polypeptide growth factors in mouse behavioural ontogenesis

E. Alleva , G. Calamandrei
Ethology Ecology & Evolution 2 ( 3) 293 -294

1990
Nerve growth factor plasma levels and ventricular repolarization in Rett syndrome.

F Guideri , M Acampa , G Calamandrei , L Aloe
Pediatric Cardiology 25 ( 4) 394 -396

19
2004